Tg(ACTA1-Il15*)11650Lsq
Transgene Detail
|
Symbol: |
Tg(ACTA1-Il15*)11650Lsq |
Name: |
transgene insertion 11650, LeBris Smith Quinn |
MGI ID: |
MGI:4417881 |
Synonyms: |
HSA-IL2SP-IL15 |
Transgene: |
Tg(ACTA1-Il15*)11650Lsq Location: unknown
|
Alliance: |
Tg(ACTA1-Il15*)11650Lsq page
|
|
Strain of Origin: |
C57BL/6 x C3H
|
|
Transgene Type: |
|
Transgenic (Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Tg(ACTA1-Il15*)11650Lsq expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Note |
mouse |
Il15 (MGI:103014) |
|
|
|
|
Mutation details: A mouse interleukin-15 (Il15) cDNA sequence encoding the mature endogenous protein (nucleotides 610-951) was modified by removing several post-transcriptional checkpoints that block efficient IL-15 translation and replacing the inefficiently translated and secreted endogenous IL-15 signal peptides with the mouse interleukin-2 (Il2) signal peptide, and stabilizing the COOH terminus of the mature IL-15 protein with a FLAG epitope tag. This IL2SP-IL15 construct was then placed downstream of a modified human alpha-skeletal actin (HSA or ACTA1) promoter fragment. A polyA signal is inserted at the 3' end of the final transgene. The resulting construct was microinjected into C57BL/6 x C3H hybrid oocyte pronuclei. Founder mice were with C57BL/6J mice to generate line 11650 (with a stable single transgene insertion point). IL-15 mRNA/protein expression in skeletal muscle is approximately 1000-fold greater in hemizygous males and approximately 800-fold/1000-fold greater in hemizygous females, respectively. Overexpression in the serum of hemizygous males and females is approximately 300-fold/500-fold, respectively.
(J:145611)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
Original: |
J:145611 Quinn LS, et al., Oversecretion of interleukin-15 from skeletal muscle reduces adiposity. Am J Physiol Endocrinol Metab. 2009 Jan;296(1):E191-202 |
All: |
2 reference(s) |
|